Macrolide and beta-lactam antibiotic combination

This page covers all Macrolide and beta-lactam antibiotic combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Bacterial 50S ribosomal subunit (azithromycin); bacterial cell wall peptidoglycan (amoxicillin).

Targets

Bacterial 50S ribosomal subunit (azithromycin); bacterial cell wall peptidoglycan (amoxicillin)

Marketed (1)

• Azithromycin and amoxicillin · University of Alabama at Birmingham · Infectious Disease
  This is a combination of two antibiotics that work by inhibiting bacterial protein synthesis (azithromycin via 50S ribosomal subunit) and inhibiting bacterial cell wall synthesis (amoxicillin via beta-lactam mechanism).

Patent intelligence

• macrolide and beta lactam antibiotic combination patent landscape — aggregated cliff calendar, attackable patents, originator estates